A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the safety, tolerability, pharmacokinetics,
pharmacodynamics, and immunogenicity of a single dose of PF-04360365 in Japanese subjects
with mild to moderate Alzheimer's Disease.